[1] 温波,刘奔,夏露.非肌层浸润性膀胱癌的外科治疗选择[J].临床泌尿外科杂志,2020,35(9):748-751.
WEN B,LIU B,XIA L.Surgical treatment options for non-muscle invasive bladder cancer[J].J Clin Urology,2020,35(9):748-751.
[2] BHATTACHARAY D,GAWALI VS,KALLAY L,et al.Therapeutically leveraging GABA(A) receptors in cancer[J].Exp Biol Med(Maywood),2021,246(19):2128-2135.
[3] YANG Y,REN L,LI W,et al.GABAergic signaling as a potential therapeutic target in cancers[J].Biomed Pharmacother,2023,161:114410.
[4] ZHANG X,ZHANG R,ZHENG Y,et al.Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer[J].J Transl Med,2013,11:102.
[5] 田男.Gabra-3基因A至ⅠRNA编辑位点的鉴定及其分子机制的研究[D].杭州:浙江大学,2010.
TIAN N.Identification and molecular mechanism of Gabra-3 RNA editing sites from A to Ⅰ[D].Hangzhou:Zhejiang University,2010.
[6] DANIEL C,VENO MT,EKDAHL Y,et al.A distant cis acting intronic element induces site-selective RNA editing[J].Nucleic Acids Res,2012,40(19):9876-9886.
[7] GUMIREDDY K,LI A,KOSSENKOV AV,et al.The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis[J].Nat Commun,2016,7:10715.
[8] PATIL V,PAL J,MAHALINGAM K,et al.Global RNA editome landscape discovers reduced RNA editing in glioma:Loss of editing of gamma-amino butyric acid receptor alpha subunit 3(GABRA3) favors glioma migration and invasion[J].PeerJ,2020,8:e9755.
[9]SILVESTRIS DA,PICARDI E,CESARINI V,et al.Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma[J].Genome Biol,2019,20(1):33.
[10] 施言,王少慧,张发明.γ-氨基丁酸及其受体在肿瘤发生发展中的作用[J].世界华人消化杂志,2012,20(5):45-50.
SHI Y,WANG SH,ZHANG FM.Role of γ-aminobutyric acid and its receptors in tumorigenesis and development[J].World Chinese Journal of Digestion,2012,20(5):45-50.
[11] LIU Y,LI YH,GUO FJ,et al.Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit[J].World J Gastroenterol,2008,14(47):7175-7182.
[12]LI YY,ZHENG XH,DENG AP,et al.MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients[J].Eur Rev Med Pharmacol Sci,2019,23(23):10433-10442.
[13] LONG M,ZHAN M,XU S,et al.MiR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer[J].Mol Cancer,2017,16(1):167.
[14] LIU J,WANG F,ZHANG Y,et al.ADAR1-mediated RNA editing and its role in cancer[J].Front Cell Dev Biol,2022,10:956649.
[15] JAIN M,JANTSCH MF,LICHT K.The editor's I on disease development[J].Trends Genet,2019,35(12):903-913.
[16] OHLSON J,PEDERSEN JS,HAUSSLER D,et al.Editing modifies the GABA(A) receptor subunit alpha3[J].RNA,2007,13(5):698-703.
[17] YU L,WEI J,LIU P.Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J].Semin Cancer Biol,2022,85:69-94.
[18]陈康,邢基,张云龙,等.PI3K/AKT/mTOR通路抑制剂在膀胱癌中的研究进展[J].现代肿瘤医学,2023,31(3):575-579.
CHEN K,XING J,ZHANG YL,et al.Research progress of PI3K/AKT/mTOR pathway inhibitors in bladder cancer[J].Modern Oncology,2023,31(3):575-579.
[19]曹李,陈鹏,李丁昌,等.p-mTOR、p-4EBP1及p-S6K1在结直肠腺癌组织中的表达及临床意义[J].中国临床解剖学杂志,2022,40(5):541-547.
CAO L,CHEN P,LI DC,et al.Expression and clinical significance of p-mTOR,p-4EBP1 and p-S6K1 in colorectal adenocarcinoma[J].Chin J Clinical Anatomy,2022,40(5):541-547.
[20] LIU L,YANG C,SHEN J,et al.GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases[J].Oncotarget,2016,7(22):32341-32350.